NCT04269941 is a clinical trial of total or subtotal gastrectomy in Gastric GIST, sponsored by Université de Sousse.

Who is sponsoring NCT04269941?

NCT04269941 is sponsored by Université de Sousse.

What drugs are being tested in NCT04269941?

Interventions in NCT04269941: total or subtotal gastrectomy.

What condition does NCT04269941 study?

NCT04269941 studies Gastric GIST.

Is NCT04269941 still recruiting?

NCT04269941 is currently completed. Last updated 17 February 2020.

Last reviewed 2020-02-17 · How we verify

NCT04269941

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prognostic Factors Affecting Survival of Gastric GIST

Completed Last updated 17 February 2020

What this trial tests

trial testing total or subtotal gastrectomy in Gastric GIST in 34 participants. Completed in 2 January 2018.

Timeline

1 January 2000

Primary endpoint
29 January 2015

2 January 2018

Quick facts

Lead sponsor	Université de Sousse
Status	Completed
Study type	OBSERVATIONAL
Enrollment	34
Start date	1 January 2000
Primary completion	29 January 2015
Estimated completion	2 January 2018

Drugs / interventions tested

total or subtotal gastrectomy

Conditions studied

Gastric GIST — all drugs for Gastric GIST →

Sponsor

Université de Sousse

Who can join

Adults 10 to 90, any sex, with Gastric GIST. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gastrointestinal stromal tumor (GIST) is the most common non-epithelial mesenchymal tumor of the gastrointestinal tract. Surgical treatment is the only curative therapy for primary localized GIST. This study aimed to identify the clinicopathological characteristics of gastric GISTs and to study the predictive factors for recurrence in Tunisian patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Université de Sousse trials

Trials by the same sponsor.

NCT04798937 — Motivational Interviewing to Improve Self Management in Youth With Type 1 Diabetes · NA · completed
NCT04649970 — Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy · completed
NCT04843670 — Isolated Pancreatic Loop With Modified Pancreaticojejunostomy · completed
NCT04709718 — Surgical Management of Giant Hepatic Hemangioma · completed
NCT04219176 — Spectral Optical Coherence Tomography Findings in Patients With Ocular Toxoplasmosis · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04269941 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université de Sousse
Last refreshed: 17 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04269941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing